证券代码：300741 证券简称：华宝股份 公告编号：2023-040 华宝香精股份有限公司 关于为控股子公司提供担保的进展公告 本公司及董事会全体成员保证公告内容不存在虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、担保情况概述 华宝香精股份有限公司（以下简称"公司"）于 2023 年 3 月 10 日召开第二 届董事会第三十二次会议，审议通过了《关于为控股子公司提供担保的议案》。 公司同意为满足控股子公司上海奕方农业科技股份有限公司（于 2023 年 6 月 30 日更名为上海奕方农业科技有限公司，以下简称"上海奕方"）业务发展的资金 需求，为其向银行申请不超过 15,000 万元的综合授信提供担保，担保额度不超 过 15,000 万元。上述担保额度的有效期为自董事会审议通过之日起 1 年。具体 内容详见公司于 2023 年 3 月 11 日在创业板信息披露网站巨潮资讯网披露的《关 于为控股子公司提供担保的公告》。 二、担保进展情况 2023 年 8 月 29 日，公司与中国民生银行股份有限公司上海分行（以下简称 "民生银行"）在上海市签订了《最高额保证合同 ...

证券代码：300741 证券简称：华宝股份 公告编号：2023-039 华宝香精股份有限公司 关于收购上海奕方部分股权的进展公告 本公司及董事会全体成员保证公告内容不存在虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、交易情况概述 华宝香精股份有限公司（以下简称"公司"）于 2022 年 3 月 8 日召开第二 届董事会第二十三次会议，审议通过了《关于收购上海奕方部分股权的议案》， 同意以 12,150 万元现金向上海克沥企业管理咨询有限公司（以下简称"上海克 沥"）、上海翰盈投资有限公司（以下简称"上海翰盈"）和上海润凯投资有限 公司（以下简称"上海润凯"）购买其合计持有的上海奕方农业科技股份有限公 司（以下简称"上海奕方"）27%的股权。同日，公司与上海克沥、上海克沥的 实际控制人 QIAN RONG（钱戎）和黄锦荣、上海翰盈、上海润凯签署《股份转 让协议》。本次交易完成后，公司对上海奕方的持股比例达到 67%，上海奕方成 为公司的控股子公司，纳入公司合并报表范围。具体内容详见公司于 2022 年 3 月 9 日在创业板信息披露网站巨潮资讯网披露的《关于收购 ...

Financial Performance - The company's revenue for Q1 2023 was CNY 341,849,030, a decrease of 17.89% compared to CNY 416,353,510 in the same period last year[15]. - Net profit attributable to shareholders for Q1 2023 was CNY 102,868,142, down 52.41% from CNY 216,153,002 year-on-year[15]. - Basic earnings per share for Q1 2023 were CNY 0.17, a decrease of 51.43% compared to CNY 0.35 in the same period last year[15]. - The total profit for the current period is 132,937,123, a decrease from 259,047,528 in the previous period, reflecting a decline of approximately 48.7%[32]. - The net profit attributable to the parent company is 102,868,142, down from 216,153,002, representing a decrease of about 52.4%[32]. - The total comprehensive income for the current period is 94,460,535, down from 217,907,615, a decline of about 56.7%[32]. - The basic and diluted earnings per share are both 0.17, down from 0.35 in the previous period, reflecting a decrease of about 51.4%[32]. Cash Flow and Assets - The net cash flow from operating activities increased significantly to CNY 14,743.29 million, a rise of 29,239.82% compared to CNY 50.25 million in the previous year[9]. - The cash flow from operating activities for the current period is 147,432,871, significantly improved from 502,501 in the previous period[35]. - The cash outflow from operating activities totals 401,113,097, a decrease from 516,531,559 in the previous period, indicating a reduction of approximately 22.3%[35]. - The company's cash and cash equivalents at the end of the first quarter were CNY 3,488,333,636, down from CNY 3,644,782,628 at the beginning of the year, reflecting a decrease of 4.3%[27]. - The cash and cash equivalents at the end of the period amount to 3,475,333,610, compared to 2,871,557,038 at the end of the previous period, showing an increase of approximately 21.1%[36]. Liabilities and Equity - The total assets at the end of the reporting period were CNY 8,663,457,560, representing a decrease of 3.85% from CNY 9,010,360,198 at the end of the previous year[15]. - The total current assets decreased to CNY 6,283,915,616 from CNY 6,559,465,474, indicating a decline of 4.2%[27]. - The total liabilities decreased to CNY 818,000,537 from CNY 1,258,661,083, a reduction of 34.9%[29]. - The total equity attributable to shareholders increased by 1.17% to CNY 7,628,701,643 from CNY 7,540,478,830 at the end of the previous year[15]. - The total equity attributable to shareholders increased to CNY 7,628,701,643 from CNY 7,540,478,830, reflecting a growth of 1.2%[29]. Operating Costs and Expenses - The total operating revenue for the first quarter of 2023 was CNY 341,849,030, a decrease of 17.9% compared to CNY 416,353,510 in the same period last year[31]. - The total operating costs for the first quarter of 2023 were CNY 234,030,583, an increase of 11.7% from CNY 209,524,333 in the previous year[31]. - The company reported a significant decrease in investment cash flow, which was CNY 1,989.91 million, down 96.74% from CNY 61,079.37 million in the previous year[9]. - The net profit for the first quarter of 2023 was impacted by a financial expense of CNY -13,190,437, compared to CNY -9,147,503 in the same period last year[31]. - Financial expenses decreased by 44.20% to CNY -1,319.04 million, attributed to an increase in fixed deposits[18]. - The company experienced a 40.11% reduction in tax and additional charges due to decreased VAT payments during the reporting period[18]. Research and Development - The company reported a research and development expense of CNY 29,455,977 for the first quarter, down from CNY 31,358,375 in the previous year, a decrease of 6.1%[31]. Shareholder Information - Liang Jue Sen holds a total of 5,855,700 shares through China Galaxy Securities and a regular securities account[53]. - Zhang De Xing holds a total of 1,463,900 shares through CITIC Securities[53]. - Feng Zhao Wei holds a total of 1,224,800 shares through China Galaxy Securities and a regular securities account[53]. - Yang Yue Feng holds a total of 1,026,900 shares through招商证券 and a regular securities account[53]. Risks and Investigations - The company has ongoing investigations involving its actual controller and board member, which may pose risks to investors[25].

Financial Performance - The company's operating revenue for 2022 was CNY 1,893,883,167, a decrease of 2.45% compared to CNY 1,941,375,258 in 2021[27] - The net profit attributable to shareholders for 2022 was CNY 724,925,228, down 27.82% from CNY 1,004,351,986 in the previous year[27] - The net profit after deducting non-recurring gains and losses was CNY 529,182,850, a decline of 37.73% from CNY 849,887,990 in 2021[27] - The net cash flow from operating activities was CNY 690,082,541, a significant drop of 44.74% compared to CNY 1,248,836,725 in 2021[27] - Basic earnings per share for 2022 were CNY 1.18, down 27.61% from CNY 1.63 in the previous year[27] - The total revenue for Huabao Flavours & Fragrances Co., Ltd. in 2022 was approximately 195.74 million, an increase from 154.46 million in 2021, representing a growth of about 26.8%[48] - The company reported total revenue from sales of goods and services of ¥2,098,735,153 for 2022, down from ¥2,393,827,710 in 2021, reflecting a decrease of about 12.3%[164] - The company achieved operating revenue of 1,893.88 million yuan, a decrease of 2.45% compared to the same period last year[95] - The edible flavor business saw a sales revenue decline of 15.57%, while the food ingredient business experienced a significant growth of 310.52%[95] - The company reported a total increase in cash and cash equivalents of CNY 1,304,128,813 for 2022, compared to a decrease of CNY -1,124,495,897 in 2021[165] Assets and Liabilities - Total assets at the end of 2022 amounted to CNY 9,010,360,198, an increase of 7.37% from CNY 8,392,050,769 at the end of 2021[27] - The company's total assets decreased from ¥8,094,343,547 on January 1, 2022, to ¥7,139,236,095 by December 31, 2022, reflecting a decline of about 11.8%[159] - The total liabilities decreased from ¥1,115,348,788 on January 1, 2022, to ¥442,875,649 by December 31, 2022, indicating a reduction of about 60%[158] - The company's accounts receivable increased to ¥659,468,738 as of December 31, 2022, from ¥462,203,052 on January 1, 2022, representing a growth of approximately 42.6%[155] - The actual guarantee balance at the end of the reporting period is CNY 12,200 million, which is 1.62% of the company's net assets[126] Research and Development - The company has focused on product and technology innovation, launching research on biotechnological preparation processes and non-meat reaction-type savory flavors[97] - The company has established a special working group to develop enteric-coated probiotic beads, achieving nearly 10 million yuan in sales orders for the new product[83] - The company emphasizes technological innovation as a foundation for high-quality development, establishing a comprehensive research platform for flavor and natural extract studies[84] - The company has established multiple laboratories for flavor and sensory evaluation, enhancing its R&D capabilities and regulatory management[98] - The company has a dedicated team of 277 R&D personnel, including 61 perfumers, with 48 senior perfumers holding advanced titles, enhancing its technical innovation capabilities[200] Market Strategy and Expansion - The company is focusing on enhancing its market expansion strategies and new product development to improve future performance[4] - The company aims to expand its market presence by developing new products and enhancing production capabilities in response to market demands[50] - The company is actively pursuing mergers and acquisitions to enhance its market presence and product range in the flavor and fragrance sector[75] - The company is actively expanding its overseas market presence, particularly in Southeast Asia and Europe, leveraging its Singapore base to enhance its product offerings and customer recognition[110] - The company is focusing on expanding its market presence in the fragrance and flavor industry, driven by the growth of downstream sectors such as food and beverage, daily chemicals, and pharmaceuticals[196] Industry Trends and Outlook - The fragrance industry is undergoing a transformation towards quality growth, with an emphasis on sustainable practices and digitalization[50] - The fragrance industry is expected to grow, with a target of reaching ¥50 billion in main business revenue by 2025, with an annual growth rate of over 2%[71] - The company anticipates that the fragrance and flavor industry will reach a revenue of 50 billion CNY by 2025, with an annual growth rate of over 2%[196] - The fragrance and flavor industry is expected to integrate into the national supply-side structural reform, promoting high-quality development during the "14th Five-Year Plan" period[198] Financial Management and Governance - The company’s financial statements have been audited and reflect a fair view of its financial position as of December 31, 2022[145] - The company has no overdue or unrecovered amounts from entrusted financial management, with a total of CNY 367,500 million in entrusted financial management during the reporting period[128] - The company has not engaged in any repurchase transactions among its top 10 shareholders during the reporting period[134] - The company has not made any significant changes to its controlling shareholder during the reporting period[135] - The actual controller of the company, Zhu Linyao, is under investigation for legal issues, as disclosed in announcements on January 24 and 27, 2022[133]

证券代码：300741 证券简称：华宝股份 公告编号：2023-023 华宝香精股份有限公司 关于举行 2022 年度业绩说明会的公告 本公司及董事会全体成员保证公告内容不存在虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 华宝香精股份有限公司（以下简称"公司"）2022 年年度报告于 2023 年 3 月 31 日披露，为了让广大投资者能进一步了解公司 2022 年度战略发展、经营管 理等情况，公司将于 2023 年 4 月 13 日（星期四）15:00 至 17:00 举行 2022 年度 网上业绩说明会。本次说明会将采用网络远程方式举行，投资者可通过以下方式 参与互动交流。 在微信中搜索"华宝股份投资者关系"，或者微信扫一扫以下二维码： 出席本次年度业绩说明会的人员有：公司董事长夏利群先生，董事、总裁袁 肖琴女士，独立董事吴昌勇先生，副总裁、财务总监张捷先生，副总裁、董事会 秘书侯晓勤女士。具体参会人员以实际出席为准。 为充分尊重投资者、提升交流的针对性，现就公司本次说明会提前向投资者 公开征集问题。投资者可于 2023 年 4 月 11 日前将有关问题通过电 ...

编号：2020-008 证券代码：300741 证券简称：华宝股份 华宝香精股份有限公司 投资者关系活动记录表 | --- | --- | --- | |--------------|-----------------------------|--------------------------------------------------------| | | √ 特定对象调研 | □ 分析师会议 | | 投资者关系活 | □ 媒体采访 | □ 业绩说明会 | | 动类别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 其他 | | | 天风证券 | 郑蔚宇、林逸丹、尉鹏洁，海通证券 曾知，华创证券 | | | 于芝欢，申万菱信 | 吴昊、孙琳，国信自营 闵晓平，绿地金控 郑 | | 参与单位名称 | 琢璞，国泰基金 | 姜英，寻常投资 孙涛，长江日晟 廖丝丝，敦 | | 及人员姓名 | 和资管 | 吴极、梁作强，青骊投资 罗晓梅，睿扬投资 安育廷，希 | | | 瓦投资 胡周，乘是资产 | 翟会会，复胜资产 陆航，睿亿投资 王 | | | 慧林，胤狮投资 | 蒋孙雪烨 | | 时 ...

证券代码：300741 证券简称：华宝股份 编号：2020-004 1 华宝香精股份有限公司 投资者关系活动记录表 | --- | --- | --- | |--------------|-----------------------------|--------------------------------------------------------------| | | √ 特定对象调研 | □ 分析师会议 | | 投资者关系活 | □ 媒体采访 | □ 业绩说明会 | | 动类别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 其他 | | 参与单位名称 | 中国人寿资产管理有限公司 | 麻锦涛、刘卓炜 | | 及人员姓名 | | | | 时间 | 2020 年 6 月 9 日 | 下午 15:00-17:00 | | 地点 | 公司会议室 | | | 上市公司接待 | 副总裁、董事会秘书 | 胡伟 | | 人员姓名 | | | | 投资者关系活 | | 胡伟先生首先介绍了公司业务板块、主要产品、 2019 年度经营业 | | 动主要内容介 | | 绩等基本情况，随后围绕下 ...

证券代码：300741 证券简称：华宝股份 编号：2020-002 1 华宝香精股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |-----------------|------------------------------|--------------------------------------------------------|------------------| | | √ 特定对象调研 | □ 分析师会议 | | | 投资者关系活 | □ 媒体采访 | □ 业绩说明会 | | | 动类别 | □ 新闻发布会 | □ 路演活动 | | | | □ 现场参观 | □ 其他 | | | 参与单位名称 | 招商证券 | 郑恺、景林资产 陈筛林 蒋彤 王雄 | 吴玉强、易同投资 | | 及人员姓名 | 张科兵 赵迪 | | | | 时间 | 2020 年 4 月 14 日 | 下午 13:30-15:30 | | | 地点 | 公司会议室 | | | | 上市公司接待 | | | | | 人员姓名 | 副总裁、董事会秘书 | 胡伟 | | | 投资者关系活 | ...

证券代码：300741 证券简称：华宝股份 编号：2019-007 华宝香精股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------|------------------------------|----------------------------------------------------------| | | √ 特定对象调研 | □ 分析师会议 | | 投资者关系活 | □ 媒体采访 | □ 业绩说明会 | | 动类别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 其他 | | 参与单位名称 | | | | 及人员姓名 | 天风证券 | 林逸丹，趣时资产 罗钊 | | 时间 | 2019 年 9 月 24 日 | 上午 10:00-11:30 | | 地点 | 公司会议室 | | | 上市公司接待 | | | | 人员姓名 | 副总裁、董事会秘书 | 胡伟 | | 投资者关系活 | 1 、公司未来的增长点在哪里？ | | | 动主要内容介 绍 | | 答：在业务拓展方面，公司将拓展食用香精、日用香精及食品配 | | ...